<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://en.longevitywiki.org/wiki/Nicotinamide_N-methyltransferase_inhibitors_(NNMTis)/history?feed=atom</id>
	<title>Nicotinamide N-methyltransferase inhibitors (NNMTis) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://en.longevitywiki.org/wiki/Nicotinamide_N-methyltransferase_inhibitors_(NNMTis)/history?feed=atom"/>
	<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/wiki/Nicotinamide_N-methyltransferase_inhibitors_(NNMTis)/history"/>
	<updated>2026-04-26T02:37:24Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.41.0</generator>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Nicotinamide_N-methyltransferase_inhibitors_(NNMTis)&amp;diff=3314&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov at 12:14, 18 July 2024</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Nicotinamide_N-methyltransferase_inhibitors_(NNMTis)&amp;diff=3314&amp;oldid=prev"/>
		<updated>2024-07-18T12:14:18Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 12:14, 18 July 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Nicotinamide N-methyltransferase inhibitors (NNMTis)&#039;&#039;&#039; treatment could surpass the muscle health benefits of resistance and endurance exercise. NNMTi treatment prevents age-associated loss of strength and actively rebuilds strength. Moreover, NNMTi treatment almost doubled the increase in muscle strength compared to exercise alone. The increases in muscle strength resulting from NNMTi treatment or exercise were additive, with the strength of the NNMTi-treated exercise cohort being increased by ~ 60% compared to the control cohort.&amp;lt;ref&amp;gt;Dimet-Wiley, A.L., Latham, C.M., Brightwell, C.R. et al. (2024). Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice. Sci Rep 14, 15554  https://doi.org/10.1038/s41598-024-66034-9&amp;lt;/ref&amp;gt;  These studies suggest that NNMTi-based drugs, either alone or combined with exercise, will be beneficial in treating sarcopenia and a wide range of age-related myopathies.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Nicotinamide N-methyltransferase inhibitors (NNMTis)&#039;&#039;&#039; treatment could surpass the muscle health benefits of resistance and endurance exercise. NNMTi &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(5-amino-1-methylquinolinium iodide&amp;lt;ref&amp;gt;Neelakantan, H., Wang, H. Y., Vance, V., Hommel, J. D., McHardy, S. F., &amp;amp; Watowich, S. J. (2017). Structure–activity relationship for small molecule inhibitors of nicotinamide N-methyltransferase. Journal of medicinal chemistry, 60(12), 5015-5028.&amp;lt;/ref&amp;gt;) &lt;/ins&gt;treatment prevents age-associated loss of strength and actively rebuilds strength. Moreover, NNMTi treatment almost doubled the increase in muscle strength compared to exercise alone. The increases in muscle strength resulting from NNMTi treatment or exercise were additive, with the strength of the NNMTi-treated exercise cohort being increased by ~ 60% compared to the control cohort.&amp;lt;ref&amp;gt;Dimet-Wiley, A.L., Latham, C.M., Brightwell, C.R. et al. (2024). Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice. Sci Rep 14, 15554  https://doi.org/10.1038/s41598-024-66034-9&amp;lt;/ref&amp;gt;  These studies suggest that NNMTi-based drugs, either alone or combined with exercise, will be beneficial in treating sarcopenia and a wide range of age-related myopathies.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Drafts]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Drafts]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Drugs]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Drugs]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
	<entry>
		<id>https://en.longevitywiki.org/index.php?title=Nicotinamide_N-methyltransferase_inhibitors_(NNMTis)&amp;diff=3310&amp;oldid=prev</id>
		<title>Dmitry Dzhagarov: Created page with &quot;&#039;&#039;&#039;Nicotinamide N-methyltransferase inhibitors (NNMTis)&#039;&#039;&#039; treatment could surpass the muscle health benefits of resistance and endurance exercise. NNMTi treatment prevents age-associated loss of strength and actively rebuilds strength. Moreover, NNMTi treatment almost doubled the increase in muscle strength compared to exercise alone. The increases in muscle strength resulting from NNMTi treatment or exercise were additive, with the strength of the NNMTi-treated exercis...&quot;</title>
		<link rel="alternate" type="text/html" href="https://en.longevitywiki.org/index.php?title=Nicotinamide_N-methyltransferase_inhibitors_(NNMTis)&amp;diff=3310&amp;oldid=prev"/>
		<updated>2024-07-17T06:46:06Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&amp;#039;&amp;#039;&amp;#039;Nicotinamide N-methyltransferase inhibitors (NNMTis)&amp;#039;&amp;#039;&amp;#039; treatment could surpass the muscle health benefits of resistance and endurance exercise. NNMTi treatment prevents age-associated loss of strength and actively rebuilds strength. Moreover, NNMTi treatment almost doubled the increase in muscle strength compared to exercise alone. The increases in muscle strength resulting from NNMTi treatment or exercise were additive, with the strength of the NNMTi-treated exercis...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Nicotinamide N-methyltransferase inhibitors (NNMTis)&amp;#039;&amp;#039;&amp;#039; treatment could surpass the muscle health benefits of resistance and endurance exercise. NNMTi treatment prevents age-associated loss of strength and actively rebuilds strength. Moreover, NNMTi treatment almost doubled the increase in muscle strength compared to exercise alone. The increases in muscle strength resulting from NNMTi treatment or exercise were additive, with the strength of the NNMTi-treated exercise cohort being increased by ~ 60% compared to the control cohort.&amp;lt;ref&amp;gt;Dimet-Wiley, A.L., Latham, C.M., Brightwell, C.R. et al. (2024). Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice. Sci Rep 14, 15554  https://doi.org/10.1038/s41598-024-66034-9&amp;lt;/ref&amp;gt;  These studies suggest that NNMTi-based drugs, either alone or combined with exercise, will be beneficial in treating sarcopenia and a wide range of age-related myopathies.&lt;br /&gt;
&lt;br /&gt;
[[Category:Drafts]]&lt;br /&gt;
[[Category:Drugs]]&lt;/div&gt;</summary>
		<author><name>Dmitry Dzhagarov</name></author>
	</entry>
</feed>